Skip to main content

Table 3 Power available for various aggregate seroconversion rates and effect sizes. Note: The interim seroconversion rate in the control arm was derived algebraically from the observed aggregate rate and the effect size

From: EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil

Interim aggregate seroconversion rate (threshold for stopping)

50% effect size

40% effect size

30% effect size

Interim seroconversion rate in control arm

Power

Interim seroconversion rate in control arm

Power

Interim seroconversion rate in control arm

Power

10%

13%

81%

12%

56%

12%

32%

15%

20%

95%

19%

76%

18%

47%

20%

27%

99%

25%

89%

24%

61%

25%

33%

> 99%

31%

96%

29%

74%

30%

40%

> 99%

37%

99%

35%

84%

33%

44%

> 99%

41%

99%

39%

88%

34%

45%

> 99%

42%

99%

40%

90%

35%

47%

> 99%

44%

> 99%

41%

91%

40%

53%

> 99%

50%

> 99%

47%

96%